BackEucrates Biomedical Acquisition Overview

Eucrates Biomedical Acquisition Other Current Liabilities

Eucrates Biomedical Acquisition's other current liabilities is $5.1K.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$5080.00

Peer average

Loading

Eucrates Biomedical Acquisition Other Current Liabilities History

Loading

Eucrates Biomedical Acquisition vs. peers: Other Current Liabilities Comparison

Loading

Eucrates Biomedical Acquisition Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Eucrates Biomedical Acquisition (EUCR) FAQ

As of the most recent data (December 2022), EUCR shows a other current liabilities of $5.1K. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EUCR's other current liabilities is now $5.1K (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Eucrates Biomedical Acquisition is outperforming or lagging.

Tracking EUCR's other current liabilities over time shows whether Eucrates Biomedical Acquisition is scaling, shrinking, or reshaping that part of the business. The current reading is $5.1K In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Eucrates Biomedical Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $5.1K) with ownership activity and broader fundamentals.